Cosmos Study September 9, 2025 Dual-Team Study Team A:Kersten Bartelt, RNJoe Deckert, PhD Team B:Blaine Franklin, PT, DPTEric Barkley Key Findings At 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight
This helps monitor the safety of medicines and identify new side effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 89.Preventive Services Task Force U.S., Curry S.J., Krist A.H., Owens D.K., Barry M.J., Caughey A.B., Davidson K.W., Doubeni C.A., Epling J.W., Jr., Grossman D.C., et al
What does long-term Semaglutide care look like
While the precise mechanism behind these headaches is not entirely clear, it is thought to be connected to the medications influence on blood vessels and neural pathways